ATE231142T1 - Cyclopropachromencarbonsäure derivate - Google Patents
Cyclopropachromencarbonsäure derivateInfo
- Publication number
- ATE231142T1 ATE231142T1 AT95934860T AT95934860T ATE231142T1 AT E231142 T1 ATE231142 T1 AT E231142T1 AT 95934860 T AT95934860 T AT 95934860T AT 95934860 T AT95934860 T AT 95934860T AT E231142 T1 ATE231142 T1 AT E231142T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- carbon atoms
- substituted
- hydrogen atom
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25646894 | 1994-10-21 | ||
| JP22536595A JP3993651B2 (ja) | 1994-10-21 | 1995-09-01 | シクロプロパクロメンカルボン酸誘導体 |
| PCT/JP1995/002163 WO1996012715A1 (fr) | 1994-10-21 | 1995-10-20 | Derives de cyclopropachromenecarboxylate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE231142T1 true ATE231142T1 (de) | 2003-02-15 |
Family
ID=26526593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95934860T ATE231142T1 (de) | 1994-10-21 | 1995-10-20 | Cyclopropachromencarbonsäure derivate |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5843988A (de) |
| EP (1) | EP0787723B1 (de) |
| JP (1) | JP3993651B2 (de) |
| AT (1) | ATE231142T1 (de) |
| DE (1) | DE69529418T2 (de) |
| ES (1) | ES2191063T3 (de) |
| WO (1) | WO1996012715A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19801647A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte beta,gamma-annellierte Lactone |
| DE19801636A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte bicyclische Lactone |
| DE19801646A1 (de) | 1998-01-17 | 1999-07-22 | Bayer Ag | Substituierte alpha,beta-annellierte Butyrolactone |
| AU2642699A (en) * | 1998-03-03 | 1999-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Remedies for brain infarction |
| GB9823845D0 (en) * | 1998-11-02 | 1998-12-23 | Lilly Co Eli | Pharmaceutical compounds |
| AU2241400A (en) | 1999-04-06 | 2000-10-12 | Yamanouchi Pharmaceutical Co., Ltd. | Novel thiazolobenzoimidazole derivative |
| GB0007193D0 (en) * | 2000-03-25 | 2000-05-17 | Univ Manchester | Treatment of movrmrnt disorders |
| US6660858B2 (en) * | 2001-03-28 | 2003-12-09 | Lion Bioscience Ag | 2-aminobenzoxazole derivatives and combinatorial libraries thereof |
| US20060166972A1 (en) * | 2003-07-11 | 2006-07-27 | Conn P J | Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator |
| MX2007000911A (es) | 2004-07-30 | 2007-04-12 | Torrent Pharmaceuticals Ltd | Nevibolol y sus sales farmaceuticamente aceptables, proceso para su preparacion y composiciones farmaceuticas de nevibolol. |
| DE102005011534A1 (de) * | 2005-03-10 | 2006-09-21 | Merck Patent Gmbh | Chromen-4-on-Derivate |
| CA2620333A1 (en) | 2005-08-26 | 2007-03-01 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
| EP1940389A2 (de) | 2005-10-21 | 2008-07-09 | Braincells, Inc. | Modulation von neurogenese durch pde-hemmung |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| DE102005062990A1 (de) * | 2005-12-28 | 2007-07-05 | Grünenthal GmbH | Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln |
| US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| MX2008014320A (es) | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| MX2009002496A (es) * | 2006-09-08 | 2009-07-10 | Braincells Inc | Combinaciones que contienen un derivado de 4-acilaminopiridina. |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| ES2522827T3 (es) * | 2009-10-30 | 2014-11-18 | Domain Therapeutics | Nuevos derivados de oximas y su uso como moduladores alostéricos de los receptores del glutamato metabotrópico |
| KR101870589B1 (ko) | 2014-08-27 | 2018-06-25 | 프렉스톤 테라퓨틱스 에스에이 | 신규 크로몬 옥심 유도체 및 대사성 글루타메이트 수용체의 알로스테릭 조절자로서의 그것의 용도 |
| AU2016313138A1 (en) | 2015-08-27 | 2018-03-15 | Prexton Therapeutics Sa | Brain-penetrant chromone oxime derivative for the therapy of levodopa-induced dyskinesia |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0723367B2 (ja) * | 1986-02-27 | 1995-03-15 | サントリー株式会社 | オキサビシクロヘプタン誘導体 |
| CA2037188A1 (en) * | 1990-06-06 | 1991-12-07 | Toshio Tatsuoka | Agent for treating disorders from cerebral neuro-degeneration |
| JP3054207B2 (ja) * | 1990-06-06 | 2000-06-19 | サントリー株式会社 | シクロプロパクロメン誘導体 |
| DE4018468A1 (de) * | 1990-06-08 | 1991-12-12 | Ultrakust Electronic Gmbh | Verfahren und vorrichtung zur entnahme einer repraesentativen milchprobe |
-
1995
- 1995-09-01 JP JP22536595A patent/JP3993651B2/ja not_active Expired - Fee Related
- 1995-10-20 AT AT95934860T patent/ATE231142T1/de not_active IP Right Cessation
- 1995-10-20 EP EP95934860A patent/EP0787723B1/de not_active Expired - Lifetime
- 1995-10-20 ES ES95934860T patent/ES2191063T3/es not_active Expired - Lifetime
- 1995-10-20 US US08/817,389 patent/US5843988A/en not_active Expired - Lifetime
- 1995-10-20 DE DE69529418T patent/DE69529418T2/de not_active Expired - Lifetime
- 1995-10-20 WO PCT/JP1995/002163 patent/WO1996012715A1/ja active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| ES2191063T3 (es) | 2003-09-01 |
| DE69529418D1 (de) | 2003-02-20 |
| US5843988A (en) | 1998-12-01 |
| EP0787723A4 (de) | 1998-02-04 |
| DE69529418T2 (de) | 2003-08-14 |
| JP3993651B2 (ja) | 2007-10-17 |
| EP0787723A1 (de) | 1997-08-06 |
| JPH08169884A (ja) | 1996-07-02 |
| WO1996012715A1 (fr) | 1996-05-02 |
| EP0787723B1 (de) | 2003-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE231142T1 (de) | Cyclopropachromencarbonsäure derivate | |
| DE69206820T2 (de) | 1,3-Dihydro-2H-Imidano 4,5-b-quinolin-2-ein Derivate als Phosphodiestenase Hemmer | |
| MY131297A (en) | Herbicides | |
| UA42684C2 (uk) | Похідні бензимідазолону та їх фізіологічно прийнятні кислотно-адитивні солі | |
| NZ509045A (en) | Intermediates in the formation of antivirally active heterocyclic azahexane derivatives | |
| DK0870768T3 (da) | Azaindol-ethylaminderivater som nikotinacetylcholinreceptor-bindingsmidler | |
| MY110447A (en) | New herbicides | |
| FI942635A (fi) | Piperatsiinijohdannaiset 5HT1A-antagonisteina | |
| DK0572093T3 (da) | Herbicide 2,6-substituerede pyridiner | |
| DE69918695D1 (de) | Sauerstoffhaltige heterocyclische verbindungen | |
| ATE144511T1 (de) | Tetrahydrobenzimidazol-derivate | |
| PE34996A1 (es) | Nuevo derivado de pirrocarbazol | |
| DE69733308D1 (de) | Aktivsauerstoffaufnehmer enthaltende pterinderivate | |
| NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
| ATE185806T1 (de) | Oxopyridylchinoxalin derivate | |
| DE60016384D1 (de) | Chondrogonese promotoren und indolin-2-on derivate | |
| ATE248598T1 (de) | Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate | |
| ATE504572T1 (de) | Derivate von aromatische heterocyclen enthaltende integraseinhibitoren | |
| MX9202178A (es) | Nuevos derivados de 2-piperacinil bencimidazol. | |
| ATE151750T1 (de) | 3-(indol-3-yl) propensäurderivate, die als nmda- antagonisten nützlich sind | |
| ES2141134T3 (es) | Derivados de carbamoil pirrolidona para el tratamiento de la depresion y de los trastornos cerebrovasculares. | |
| DE69116302D1 (de) | 4-[4- oder 6-(Trifluormethyl-2-pyridinyl)]-1-piperazinyl-alkyl substituierte Laktame | |
| DE69303847T2 (de) | Indolderivate | |
| ATE194621T1 (de) | Pyrazolothiazolopyrimidin-derivate | |
| MX9708891A (es) | Piperidinas n-(arilmetil substituidas)-4-(bis(fenil o piridil substituidas)metil)insecticidas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |